Clinical Trials Browser

NCT01366144 2026-04-13

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Unknown Primary, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Liver Failure, Renal Insufficiency

Clinical Trials

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

LIVERAL

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Quantitative MRI and Outcomes of Liver Resection

BCAA in HCC

Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI

HEPARIM

ARAPS

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Mobilization of Mesenchymal Stem Cells During Liver Transplantation

Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Use of N-Acetylcysteine During Liver Procurement

EPOCAL